Similar articles

• Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.

  Kwok CS, Shoamanesh A, Copley HC, Myint PK, Loke YK, Benavente OR. Kwok CS, et al. Stroke. 2015 Apr;46(4):1014-23. doi: 10.1161/STROKEAHA.114.008422. Epub 2015 Feb 26. Stroke. 2015. PMID: 25721018
• Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.

  Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
• Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

  SPS3 Investigators; Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA. SPS3 Investigators, et al. N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133. N Engl J Med. 2012. PMID: 22931315 Free PMC article. Clinical Trial.
• Antiplatelet Therapy in Cerebral Small Vessel Disease.

  Bouasquevisque DS, Benavente OR, Shoamanesh A. Bouasquevisque DS, et al. Curr Neurol Neurosci Rep. 2019 Jul 27;19(9):61. doi: 10.1007/s11910-019-0979-y. Curr Neurol Neurosci Rep. 2019. PMID: 31352655 Review.
• Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.

  Moustafa B, Testai FD. Moustafa B, et al. Curr Neurol Neurosci Rep. 2022 Nov;22(11):789-802. doi: 10.1007/s11910-022-01237-z. Epub 2022 Oct 13. Curr Neurol Neurosci Rep. 2022. PMID: 36227497 Review.